Search

Displaying results 3421 - 3430 of 6076 in total
  1. Drug

    ABT-560

    go.drugbank.com/drugs/DB06093
    Experimental

    ABT-560 is a neuronal nicotinic receptor (NNR) modulator, which has shown promise in preclinical models relevant for the treatment of cognitive deficits.

  2. Drug

    ATG003

    go.drugbank.com/drugs/DB05069
    Investigational

    ATG003, a novel anti-angiogenic drug candidate and a formulation of mecamylamine, is currently in clinical development for neovascular age-related macular degeneration.

  3. Drug

    Dimethyl sulfone

    go.drugbank.com/drugs/DB14090
    Investigational

    Mixtures: Conart-MSM Sachet for Oral Solution, Condrosa-MSM Sachet for Oral Solution
  4. Drug

    Zoalene

    go.drugbank.com/drugs/DB11480
    ExperimentalVet approved

    Dinitolmide is a fodder additive for prophylaxis against coccidiosis infections in poultry.

  5. Drug

    Adomeglivant

    go.drugbank.com/drugs/DB11704
    Investigational

    Adomeglivant has been investigated for the basic science of Type 2 Diabetes.

  6. Drug

    Salanersen

    go.drugbank.com/drugs/DB18418
    Investigational

    BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.

  7. Drug

    Mannose

    go.drugbank.com/drugs/DB12907
    Investigational

    Mannose is under investigation for the basic science of IUGR and Pregnancy.

  8. Drug

    Hypericin

    go.drugbank.com/drugs/DB13014
    Investigational

    Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.

  9. Drug

    Mapracorat

    go.drugbank.com/drugs/DB12041
    Investigational

    Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.

  10. Drug

    Losmapimod

    go.drugbank.com/drugs/DB12270
    Investigational

    Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.